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Introduction 
The experience of pain represents not just a sensorial
process, but a complex perception involving the superior
levels of the central nervous system, emotional states and
higher mental processes. Besides an analgesic therapy, a
global approach to pain treatment also considers, in the
majority of chronic pain patients, the intercurrent situa-
tional and emotional pathogenetic elements towards a
multilateral intervention model.
In this study, we aimed to evaluate the occurrence of
mood, anxiety and disability disorders in 300 patients
affected by chronic daily headache and MOH, who were
observed for a 16-month period in our centre.
This symptomatology necessarily recalls the correla-
tion between somatic and psychic aspects, mind and body,
medicine and psychiatry. The acknowledged comorbidity
concerning pain and mood disorders should entail the
association of an antalgic therapy with an adequate treat-
ment against depression and anxiety. Epidemiological
research showed that mood disorders occurred in a great
number of patients affected by headache [1].
A multicenter Italian study focused attention on the high
comorbidity level between mood disorders and tension-type
headache, determining a psychiatric comorbidity of 85% [2].
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Abstract The aim of the study was
to estimate the occurrence of mood,
anxiety and disability disorders in
300 patients affected by chronic
daily headache and MOH, who
were observed for a 16-month peri-
od in our centre. We monitored the
patients on an interview basis, con-
cerning the anamnestic data collec-
tion related to the pre-morbid peri-
od, information given by relatives
regarding the patient’s behaviour
during the day, attitudes towards
others, maintenance of previous
interests and enjoyments, and modi-
fications of the biological rhythm.
Several tests were conducted,
underlining a significant correlation
between headache and mood disor-
ders, impairment of working activi-
ty, social and family life. The study
shows that patients affected by
chronic daily headache and MOH
present high levels of anxiety, a
depressive symptomatology associ-
ated with alexithymia. Moreover, it
has been discovered that anxiety
and depression facilitate the onset
of headache, while patients suffer-
ing from pain persistence were
more vulnerable to psychiatric
problems. In consideration of these
results, more exhaustive evaluations
relating to the psychopathological
aspects in patients affected by
headache are necessary.
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Several papers have dealt with the relationship
between pain and depression in order to establish if
depressive symptoms precede or follow chronic pain [3].
These studies propose three hypotheses:
1. Depression induces chronic pain by incrementing the
sensibility to the pain itself and reducing the tolerance
limit [4].
2. Depression is a psychological reaction to chronic pain,
determining a disabling physical condition and a
reduction in both social and physical activities [5].
3. Pain and depression underlie common pathogenetic
mechanisms, both psychological and biological, repre-
sented by the role of biogenic amines (serotonin and
noradrenaline) [6].
In our study, we monitored the patients on an interview
base, concerning the anamnestic data collection related to
the pre-morbid period, information given by relatives
regarding the patient’s behaviour during the day, attitudes
toward others, maintenance of previous interests and grat-
ifications, and modifications of the biological rhythm. Our
aim was to evaluate the interdependence between
headache and humoral disorders.
Materials and methods
A total of 300 patients, (100 males, 200 females, M:F 1:2;
aged 25–50 years, mean age 36.44 years), diagnosed with
chronic daily headache and MOH, were enrolled in the study.
The average duration of illness was 15 years. Exclusion crite-
ria were: acute and disabling concomitant psychiatric patholo-
gies, either functional or diagnosed on axis III of DSM-IV,
treatment with antidepressants, benzodiazepines, and
antiepileptics [7].
The patients were observed for 16 months in our Regional
Referral Headache Centre and underwent several trials with
evaluation measures such as Sheehan Clinician Rated Anxiety
Scale (SCRAS), Social Adaptation Self-evaluation scale (SAS),
HAMILTON-D, and Disability Scale (DISS).
SCRAS was administered to evaluate in general the severity
of anxiety symptoms and of both panic and phobic disorders.
The trial was composed of 35 items, which explore subjective
symptoms that appeared during, or in consequence of, critical
anxiety episodes during the previous week [8].
SAS contains items expressing positive aspects, such as level
of cooperation, happiness, sense of humour, sense of responsi-
bility, etc. [9].
The Hamilton-D scale, composed of 21 items, is particularly
adequate for measuring depressive symptomatology in adult
patients. The first 17 items are generally considered key for
depression and define the cut-off of severity, which can be
schematized: >25, severe depression; 18–24, moderate depres-
sion; 8–17, mild depression; <7, absence of depression [9].
DISS measures the impairment rank of working activities
(item 1), social life (item 2), family life (item 3), stress perceived
by the patient (4), and social support received (5). This scale
proved to be reactive in recognizing different types of active
treatments [10].
Results
Of the sample (Table 1), 200 patients (45 men and 155
women) had a Hamilton-D score that varied from 12 to
>25, particularly with respect to the first 17 items regard-
ing depression. The items with highest results were those
representing anxiety and somatisation disorders (10 “psy-
chic anxiety”, 11 “somatic anxiety”, 12 “gastrointestinal
somatic symptoms”, 13 “general somatic symptoms”, 15
“hypochondriasis”, 17 “insight”), cognitive disorders (2
“guilt feelings”, 9 “agitation”, 21 “obsessive compulsive
symptoms”) and slowdown (1 “depressed mood”, 7 “work
and interests”, 8 “slowdown”, 14 “genital symptoms”).
Of particular significance are the results relating to
item 3, “suicide”, where 42 patients (21%) gave the fol-
lowing answers: (1) I think that life is not worth living
(42.85%); (2) I wish I was dead or I have considered the
possibility of suicide (42.85%); (3) I have made attempts
to commit suicide (14.3%).
This positivity to the Hamilton-D scale is supported by
an analogous positivity on the SCRAS scale (Tables 2, 3,
4). In this scale, the first 16 items evaluate panic symp-
Table 1 Hamilton-D score (n=200)
Item Patients, n %
Depressed mood 150 75
Feelings of guilt 117 58.5
Suicide 42 21
Early insomnia 126 63
Middle insomnia 96 48
Late insomnia 108 54
Work and activities 120 60
Retardation: psychomotor 75 37.5
Agitation 141 70.5
Psychological anxiety 159 79.5
Somatic anxiety 168 84
Somatic symptoms (gastrointestinal) 48 24
General somatic symptoms 177 88.5
Genital symptoms 75 32.5
Hypochondriasis 84 42
Loss of weight 57 28.5
Insight 51 25.5
Diurnal variation 117 58.5
Depersonalization and derealisation 12 6
Paranoid symptoms 18 9
Obsessional and compulsive symptoms 24 12
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toms, which occurred during the previous week (Table 2),
those ranging from 17 to 20 evaluate the presence of spon-
taneous or situational panic attacks and of anticipated
anxiety (Table 3), and the last 15 items evaluate specific
symptoms of anxiety (hesitation, obsessiveness, somatisa-
tion, etc.) (Table 4).
Table 2 SCRAS score: items 1–16. Data are expressed as percentage (n=200)
Item Minimal Moderate Severe Extreme
Dizziness 25.5 24.0 1.5 7.5
Weakness in legs 9.0 28.5 6.0 6.0
Unstable balance 15.0 21.0 1.5 3.0
Dyspnoea 19.5 6.0 7.5 1.5
Tachycardia 19.5 18.0 3.0 3.0
Chest pain 9.0 7.5 6.0 1.5
Smothering sensations 12.0 16.5 6.0 1.5
Paraesthesia 7.5 9.0 3.0
Burst of heat 5.0 27.0 7.5 6.0
Sickness 21.0 24.0 7.5 3.0
Diarrhoea 16.5 9.0 4.5
Headaches 16.5 33.0 30.0 12.0
Tiredness 28.5 27.0 16.5 10.5
Increased sensitivity to light, sound 22.5 21.0 9.0 12.0
Sweating 16.5 16.5 10.5 3.0
Derealisation 6.0 9.0 1.5 3.0
Table 3 SCRAS score: items 17–20. Data are expressed as percentage (n=200)
Item Minimal Moderate Severe Extreme
Depersonalisation 6.0 9.0 1.5 3.0
Hypochondria 21.0 7.5 3.0 3.0
Fears of going mad 7.5 12.0 3.0 2.0
Danger sensations 18.0 10.5 10.5 1.0
Table 4 SCRAS score: items 21–35. Data are expressed as percentage (n=200)
Item Minimal Moderate Severe Extreme
Shaking or shivering 19.5 10.5 3.0 1.5
Increased depression 24.0 16.5 6.0 3.0
Emotional lability 24.0 16.5 10.5 3.0
Dependence from others 15.0 10.5 6.0 1.5
Compulsive thoughts 3.0 5.0 3.0
Obsessive thoughts 18.0 15.0 3.0 3.0
Initial insomnia 24.0 10.5 3.0 7.5
Central insomnia 15.5 7.5 3.0 7.5
Phobias 7.5 12.0 1.5 3.0
Irritability 30.0 33.0 12.0 16.5
Anxiety due to job interview 21.0 21.0 3.0 3.0
Panic attacks 10.5 3.0 3.0 3.0
Spontaneous anxiety 13.5 13.5 3.0 3.0
Anticipating anxiety 19.5 13.5 6.0 6.0
Situational panic attacks 12.0 4.5 3.0 4.5
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We also analysed the DISS, a scale for self-evaluation
of the level of compromise in the areas of working life and
social life. We discovered that in 13% of cases, the patient’s
symptoms mildly interrupted work or study, 38% moder-
ately interrupted, 39% markedly, and in 8% severely. This
data reoccurs in compromising social life and/or leisure
activities, where 14% answered mildly, 48% moderately,
17% markedly, and l8% severely. The last statistic high-
lights a mild compromise in family life for 17% of persons,
moderate for 39%, markedly for 22%, and severely for l8%.
Conclusions  
From the study it emerges that patients affected by chron-
ic daily headache and MOH present high levels of altered
regulation of affectivity, tending to react excessively to
minor stresses. Many patients suffer from persistent phys-
ical complaints that often require medical or therapeutic
interventions, which depend on the release of endogenous
hormones in response to stress. Chronic exposure to stress
factors leads to significant compromise in the effective-
ness of this system, thus resulting in an inferior threshold
to various stimulants compared with that of non-chronic
patients. Overproduction of catecholamine, which results
in a general sensation of anxiety and insomnia, with
reduced production of cortisol, is one of the many neuro-
hormonal disorders involved in this conclusion [11].
Further evidence supporting the recognition of mood
disorders is the fact that the deflection of mood tone
implies an important amplification of the organic sympto-
matology of the base illness, determining an aggravation
of the pain component. Deflection of mood tone interferes
with the quality of life, inducing aggravation on a par with
other organic variables [12]. These results necessitate
more in-depth evaluation of the psychopathological ten-
dencies of all patients who refer to a headache centre.
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